CN100518784C - Externally applied medicine of traumatic injury, rheumatic arthralgia - Google Patents
Externally applied medicine of traumatic injury, rheumatic arthralgia Download PDFInfo
- Publication number
- CN100518784C CN100518784C CNB2005100989310A CN200510098931A CN100518784C CN 100518784 C CN100518784 C CN 100518784C CN B2005100989310 A CNB2005100989310 A CN B2005100989310A CN 200510098931 A CN200510098931 A CN 200510098931A CN 100518784 C CN100518784 C CN 100518784C
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- pains
- traumatic injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses an external medicine of a bambooleaf pricklyash root, which is prepared from bambooleaf pricklyash roots, dragon blood, lanceleaf anisetree roots, common mappianthus stThe present invention is one kind of externally applied medicine. The medicine is prepared with five kinds of Chinese medicinal materials including cannalike dona rhizome, dragon's blood, lanceleaf anems, beautiful sweetgum roots and etanol (concentration is 75%) according to certain weight proportion. The medicines are combined to perform the synergistic function of the efficacy of each medicine,isetree root, common mappianthus stem and beautiful sweetgum root in certain proportion as well as alcohol solution in 75 % concentration. The synergistic effect of the Chinese medicinal materials mak and thus, the present invention can effectively treat the diseases of injuries from falls, rheumatic pains, pains in waists and knees, aching pains in joints, muscle and bone injuries from falls, aches the externally applied medicine possess high and determined effect and short treatment period on traumatic injury, rheumatalgia, rheumarthritis, soft tissue injury and other diseases. ing pains in sclerometers, painful swellings with blood stasis, soft tissue contusion, joint sprains, rheumatic arthralgia, rheumatic arthritis pains, and painful swellings from falls with definite curative effects, short treatment course and good effects.
Description
Technical field:
The present invention relates to a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis.
Background technology:
The traumatic injury disease is a kind of common disease, it is a lot of from ancient times to the present to suffer from the somebody, be subjected to ailing the torment deeply, the various medicine for external use of Xiao Shouing are also a lot of in the market, but no matter be Western medicine or Chinese medicine, slight illness for this class Drug therapy traumatic injury has played certain therapeutical effect really, but does not also have a kind of specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at pressing for of patient, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of very ideal traumatic injury.
Purpose of the present invention just provides a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis.
Choice of drug Radix Zanthoxyli Planispini of the present invention, Sanguis Draxonis, Radix Illicii Lanceolati, Radix Saposhnikoviae, Radix Antenoronis Filiformis, Caulis Mappianthi Iodoidis, Radix Liquidambaris, ethanol (concentration is 75%) are formed; Wherein select Radix Zanthoxyli Planispini for use: have expelling wind and cold, promoting blood circulation and stopping pain; Control traumatic injury, rheumatic arthritis.Select Sanguis Draxonis for use: have the dissipating blood stasis analgesic therapy, the pain relieving granulation promoting; Control traumatic injury, internal injury pain, trauma bones and muscles pain.Select Radix Illicii Lanceolati for use: have eliminating stasis to stop pain, dispelling wind and removing obstruction in the collateral; Control traumatic injury, rheumatic arthralgia.Select Radix Saposhnikoviae for use: have expelling wind and dampness, deliver pain relieving; Control anemofrigid-damp arthralgia, joint is ached.Select Radix Antenoronis Filiformis for use: have eliminating stasis to stop pain, detumescence is invigorated blood circulation; Control traumatic injury, traumatic injury muscles and bones is hindered.Select Caulis Mappianthi Iodoidis for use: have expelling wind and removing dampness, pain relieving is active; Dispelling the wind and dampness pathogens arthralgia, rheumatoid arthritis.Select Radix Liquidambaris for use: have expelling wind and removing dampness.Dispelling the wind and dampness pathogens arthralgia.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treating that traumatic injury, rheumatalgia, lumbocrural pain, joint aches, traumatic injury muscles and bones are hindered, joint is ached, blood stasis swells and ache, the curative effect of disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis pain, treating swelling and pain by traumatic injury is definite, the course of treatment is shorter, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
1-15 parts of Radix Zanthoxyli Planispinis, 1-12 parts of Sanguis Draxonis, 1-12 parts of Radix Illicii Lanceolatis, 1-12 parts of Radix Saposhnikoviaes, 1-6 parts of Radix Antenoronis Filiformiss, 1-12 parts of Caulis Mappianthi Iodoidiss, 1-12 parts of Radix Liquidambariss, 30-260 parts of ethanol (concentration is 75%).
Optimization formula of the present invention is:
13 parts of Radix Zanthoxyli Planispinis, 10 parts of Sanguis Draxonis, 10 parts of Radix Illicii Lanceolatis, 10 parts of Radix Saposhnikoviaes, 4 parts of Radix Antenoronis Filiformiss, 10 parts of Caulis Mappianthi Iodoidiss, 10 parts of Radix Liquidambariss, concentration of alcohol are 75%) 220 parts.
A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to that treatment traumatic injury, rheumatalgia, lumbocrural pain, joint aches, traumatic injury muscles and bones are hindered, joint is ached, blood stasis swells and ache, the disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis pain, treating swelling and pain by traumatic injury; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares better efficacy with existing similar medicine for external use curative effect.A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis of the present invention was once done a large amount of clinical trials in early stage, inferior between 1992-2005 years to over one hundred example on the patient treatment case, comprise be used for the treatment of that traumatic injury, rheumatalgia, lumbocrural pain, joint aches, traumatic injury muscles and bones are hindered, joint is ached, blood stasis swells and ache, the disease of soft tissue contusion, articular sprain, rheumatic arthritis, rheumatic arthritis pain, treating swelling and pain by traumatic injury, do not see untoward reaction during the treatment.Total effective rate is more than 83%, and the treatment works well.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, rub with the hands or the tip-tap affected part with the palm of the hand then, and be good to making the affected part heating, every day 3-6 times.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis provided by the present invention is made up of the component of following parts by weight; 1-15 parts of Radix Zanthoxyli Planispinis, 1-12 parts of Sanguis Draxonis, 1-12 parts of Radix Illicii Lanceolatis, 1-12 parts of Radix Saposhnikoviaes, 1-6 parts of Radix Antenoronis Filiformiss, 1-12 parts of Caulis Mappianthi Iodoidiss, 1-12 parts of Radix Liquidambariss, 30-260 parts of ethanol (concentration is 75%).
Embodiment 2:
Optimization formula of the present invention is:
13 parts of Radix Zanthoxyli Planispinis, 10 parts of Sanguis Draxonis, 10 parts of Radix Illicii Lanceolatis, 10 parts of Radix Saposhnikoviaes, 4 parts of Radix Antenoronis Filiformiss, 10 parts of Caulis Mappianthi Iodoidiss, 10 parts of Radix Liquidambariss, 220 parts of ethanol (concentration is 75%).
Preparation method of the present invention is: at first with above-mentioned Radix Zanthoxyli Planispini, Sanguis Draxonis, Radix Illicii Lanceolati, Caulis Mappianthi Iodoidis, Radix Liquidambaris, the single granularity control of grinding into is as the grain of rice between the size respectively, granule after each single pulverizing is mixed in proportion mixes together evenly, be placed in the container then, and allocate ethanol (concentration is 75%) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or after soaking 15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.
Claims (2)
1, a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis is characterized in that: formed through soak with ethanol by following medicine materials in portions by weight: 1-15 parts of Radix Zanthoxyli Planispinis, 1-12 parts of Sanguis Draxonis, 1-12 parts of Radix Illicii Lanceolatis, 1-12 parts of Radix Saposhnikoviaes, 1-6 parts of Radix Antenoronis Filiformiss, 1-12 parts of Caulis Mappianthi Iodoidiss, 1-12 parts of Radix Liquidambariss, concentration are 30-260 parts of 75% ethanol.
2, a kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis according to claim 1 is characterized in that: formed through soak with ethanol by following medicine materials in portions by weight: 13 parts of Radix Zanthoxyli Planispinis, 10 parts of Sanguis Draxonis, 10 parts of Radix Illicii Lanceolatis, 10 parts of Radix Saposhnikoviaes, 4 parts of Radix Antenoronis Filiformiss, 10 parts of Caulis Mappianthi Iodoidiss, 10 parts of Radix Liquidambariss, concentration are 220 parts of 75% ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100989310A CN100518784C (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of traumatic injury, rheumatic arthralgia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100989310A CN100518784C (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of traumatic injury, rheumatic arthralgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1739708A CN1739708A (en) | 2006-03-01 |
| CN100518784C true CN100518784C (en) | 2009-07-29 |
Family
ID=36092333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100989310A Expired - Fee Related CN100518784C (en) | 2005-09-11 | 2005-09-11 | Externally applied medicine of traumatic injury, rheumatic arthralgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100518784C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103356789A (en) * | 2013-07-22 | 2013-10-23 | 兰州理工大学 | Zanthoxylum armatum total alkaloids extract, and preparation method and application thereof |
-
2005
- 2005-09-11 CN CNB2005100989310A patent/CN100518784C/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 活血化瘀法在骨伤科中的应用. 李长信.中国中西医结合外科杂志，第6期. 1995 |
| 活血化瘀法在骨伤科中的应用. 李长信.中国中西医结合外科杂志，第6期. 1995 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1739708A (en) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100506253C (en) | Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls | |
| CN100420473C (en) | Externally applied medicine of dunn tongoloa root | |
| CN100518784C (en) | Externally applied medicine of traumatic injury, rheumatic arthralgia | |
| CN100551418C (en) | A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis | |
| CN100420476C (en) | Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls | |
| CN100540020C (en) | A kind of Flos Carthami medicine for external use | |
| CN100551415C (en) | A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis | |
| CN100531780C (en) | Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae | |
| CN1814232B (en) | Wind-repellent collateral-flow-activating pain-relieving medicine of herba cissampeloris pareirae | |
| CN1739624A (en) | Externally applied medicine of aizoon stonecrop root | |
| CN100420462C (en) | Externally applied medicine of avicenna's pricklyash root | |
| CN1813992A (en) | Radix-zauthoxyli-Plamispini external-use collateral-flow-activating medicine for treating injuries from falls | |
| CN100518791C (en) | Externally applied medicine of traumatic injury, rheumatic arthralgiaf | |
| CN100534512C (en) | Externally applied medicine of Yunan camptandra root | |
| CN100534475C (en) | Externally applied medicine of sequin lobelia | |
| CN100518778C (en) | Externally applied medicine of traumatic injury, rheumatic arthralgia | |
| CN100542549C (en) | A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis | |
| CN100542570C (en) | A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis | |
| CN1814213B (en) | Wind-repellent pain-relieving medicine containing ardisia gigantifolia stapf | |
| CN1739644A (en) | Externally applied medicine of fortune silene herb | |
| CN100420474C (en) | Collateral-flow-activating pain-relieving medicine of Radix Tongoloae Dunnii | |
| CN100551406C (en) | A kind of medicine for external use for the treatment of traumatic injury, rheumatic arthritis | |
| CN1751709A (en) | External use medicine for treating traumatic injury | |
| CN1739636A (en) | Externally applied medicine of Chinese tinospora stem | |
| CN1739646A (en) | Externally applied medicine of thickleaf croton root |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090729 |